Effect of Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Circulation
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of the P-selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial
Circulation 2023 Jun 25;[EPub Ahead of Print], SD Solomon, CJ Lowenstein, AS Bhatt, A Peikert, O Vardeny, MN Kosiborod, JS Berger, HR Reynolds, S Mavromichalis, A Barytol, AD Althouse, JF Luther, ES Leifer, AL Kindzelski, M Cushman, MN Gong, LZ Kornblith, P Khatri, KS Kim, L Baumann Kreuziger, L Wahid, BA Kirwan, MW Geraci, MD Neal, JS HochmanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.